Revenue (in std. metal prices) is expected to be approximately EUR 2.37-2.52bn, and operational EBITDA is expected to be approximately EUR 330-380m. The financial outlook is based on several ...
Image: Mariana Proenca via Unsplash. This week, several module distributors told PV Tech that they had received messages from suppliers indicating that some PV module manufacturers are considering ...
3.00 p.m. (CET) with doors opening from 2.30 p.m. (CET) at Glostrup Park Hotel, Hovedvejen 41, 2600 Glostrup. Attached are the integrated annual report, invitation and agenda with the full contents of ...
This content is protected by copyright and may not be reused. If you want to cooperate with us and would like to reuse some of our content, please contact: [email protected].
Entries are now open for the pv magazine Awards 2025. We want to hear from the very best solar and storage businesses and individuals as we celebrate excellence across our industry. We’re ...
Many people with polycythemia vera (PV) live a normal life with this rare blood cancer under control. The goal is to avoid complications like blood clots, which may happen because PV thickens your ...
Polycythemia vera (PV) is a blood cancer that begins in the marrow of your bones, the soft center where new blood cells grow. It causes your marrow to make too many red blood cells so your blood ...
European Energy has successfully commissioned its first PV project in Australia, its 58MW Mokoan solar park (pictured). Located in Victoria State, construction of the solar park began in the first ...
Vestas has opened a new corporate office in Houston, Texas – the energy capital of the United States. The wind turbine manufacturer currently employs more than 500 people in the state of Texas.
The mucosal form of Pemphigus Vulgaris (PV) has Desmoglein3 (Dsg3), whereas the cutaneo-mucous form has Dsg3and Dsg1. Paraneoplastic Pemphigus (PNP) has many antigens, including those of Pemphigoid ...
Antitumor activity of immune cells such as T cells and NK cells has made them auspicious therapeutic regimens for adaptive cancer immunotherapy. Enhancing their cytotoxic effects against malignancies ...